Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea - Wikidata - wikimedia - TriplyDB

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

http://www.wikidata.org/entity/Q33662847

about

Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study.

P2860

Q47727775-01ADA557-9D97-4665-BC5C-62557953D46A

P2860

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

http://www.wikidata.org/entity/Q33662847

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

@ast

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

@en

type

label

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

@ast

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

@en

prefLabel

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

@ast

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

@en

P1433

Q33662847-DF84219A-4D42-40C0-A52E-7BF7B3144B22

P1476

Q33662847-EB63A108-4DE5-45C3-AD5C-27DEEE3169BC

P2093

Q33662847-1015B442-6F69-4E4C-B6B6-F2B350BE3428

Q33662847-22077487-5C3B-4B71-B297-076E2D93C156

Q33662847-2C378632-34A4-4495-9EE4-13A993456107

Q33662847-2F48BB7C-5657-4620-94BC-7AEE8C0B4C6B

Q33662847-46A5B4EC-3418-4F37-97BE-704A156FCF69

Q33662847-5243EF28-517B-45A2-8474-0EECA3149E38

Q33662847-79EB199E-A186-4BA0-A8E8-4357F728044B

Q33662847-7DACAAA6-0E83-4A60-8A00-92F4097B28B8

Q33662847-AE6B899E-305B-47BB-8635-828127AD6406

Q33662847-FF6A8ACE-2F8F-4F3B-B46A-E5D690A7750D

P2860

Q33662847-03858AA8-D2EA-4DCD-895B-32E61A9364FC

Q33662847-178FC3BC-50B1-410B-949F-E6C1CA921250

Q33662847-330935B0-79A0-46BE-A7A6-B97580BB97EB

Q33662847-34720997-5C6E-4106-AC31-FDC87BFB1A9A

Q33662847-3529F05D-69CE-44D3-8363-615698CA2775

Q33662847-3DD7F8B4-534C-41E2-8C9B-8554FA14C6A1

Q33662847-5B8D2D3E-81F1-4F84-B20B-6DD4D3E9E6A1

Q33662847-6C868976-AD5E-4DA2-BB20-35D82EDF4DC8

Q33662847-6E5FF99B-400A-44A0-89B5-83291A173E8B

Q33662847-8A31F01A-5F84-4CE8-B532-9AC97F93D028

P304

Q33662847-1D3CCE3A-59D3-4990-91B1-52CB064E8DAD

P31

Q33662847-F5DCE139-8368-4DFC-9B72-B42DB388FB11

P356

Q33662847-995CE202-003F-4FB3-A581-D191FA62DFDB

P433

Q33662847-0C7A7B44-9050-44E0-B8FF-C5F179902847

P478

Q33662847-C9D0C395-D0CA-4708-BD33-AC084593AC3C

P577

Q33662847-41AAC2C7-0306-4BC5-927D-2D63E77924BE

P698

Q33662847-15A8003B-911F-4F86-84D0-13A1DC1A2EB2

P932

Q33662847-BACB2F25-EC4B-4CDF-B9CE-3475B599AB0D

P356

CPN.2017.15.2.177

P1433

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

P1476

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

@en

P2093

Dae-Bo Lee

http://www.w3.org/2001/XMLSchema#string

Duk-In Jon

http://www.w3.org/2001/XMLSchema#string

In Hee Shim

http://www.w3.org/2001/XMLSchema#string

Jonghun Lee

http://www.w3.org/2001/XMLSchema#string

Moon-Doo Kim

http://www.w3.org/2001/XMLSchema#string

Sang-Yeol Lee

http://www.w3.org/2001/XMLSchema#string

Seunghee Won

http://www.w3.org/2001/XMLSchema#string

Won-Myong Bahk

http://www.w3.org/2001/XMLSchema#string

Young Sup Woo

http://www.w3.org/2001/XMLSchema#string

Young-Eun Jung

http://www.w3.org/2001/XMLSchema#string

P2860

Aripiprazole versus other atypical antipsychotics for schizophrenia

Aripiprazole: from pharmacological profile to clinical use

Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.

Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163).

Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data.

Extrapyramidal side effects are unacceptable.

Extrapyramidal side effects with atypical neuroleptics in bipolar disorder.

Aripiprazole in schizophrenia and schizoaffective disorder: A review.

Patterns of atypical antipsychotic subtherapeutic dosing among Oregon Medicaid patients.

Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder.

P304

177-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.9758/CPN.2017.15.2.177

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28449566

http://www.w3.org/2001/XMLSchema#string

P932

5426486

http://www.w3.org/2001/XMLSchema#string